Biotechnology Companies Worldwide
Biotechnology companies develop, manufacture, and distribute medical devices, diagnostics, or pharmaceutical products for use in clinical, hospital, and research settings. This page lists companies operating in the Biotechnology sector based on self-reported profile data. The directory currently holds 792 companies in this sector. The largest share of listings is based in United States (US). Related sectors on Enterprise League include Medical Equipment and Services, Life Science, Genetics, Pharmaceutical, Biopharma, Clinical Trials, Nanotechnology.
792 companies
United States (US) top country
Location
Category
Biotechnology
List of Biotechnology companies in All locations
792 companies
Sort by
Axitan is a UK biotech company focused on eliminating antibiotics from animal feed and improving productivity. It is developing a library of endolysins, and associated products, capable of targeting those pathogens that impact livestock farming historically managed through antibiotic supplements in animal feed and, in so doing, improve productivityyields. Its focus forms part of wider WHO One Health initiative to combat the threat posed by antimicrobial resistance caused by the overuse of antibiotics, animals accounting for two thirds of the antibiotics consumed globally each year. In October 2022, Axitan achieved US FDA GRAS (“Generally Recognised As Safe”) status for the algal biomass ingredient used in its first product, FORC3®, which promotes healthy growth in poultry by targeting the pathogen Clostridium perfringens that causes $6b of economic loss each year to the poultry industry. Axitan has operations in the UK and US.
Biotechnology
Link Biologics is on a mission to develop Link_TSG6 as a superior treatment for the life-limiting effects of inflammatory and degenerative disorders. Link_TSG6 is based on TSG-6, a human protein with an endogenous role to protect tissues from inflammatory damage.
Our lead programme, Dry Eye Disease (DED), is an inflammatory condition where patients experience persistent eye irritation, blurred vision, pain and decreased quality of life. Approximately 350 million people live with DED worldwide.
Biotechnology
At VikingGenetics, we breed healthy, efficient, trouble-free cows. We provide science-based bovine genetic products and solutions for progressive dairy and beef producers around the world. Our passion is to help you as a farmer achieve your business goals, farm sustainably, and enjoy life.
As a co-operative, VikingGenetics has 16,000 members - dairy and beef farmers from Denmark, Sweden, and Finland. We focus on animal welfare, food security, and reducing climate impact in our entire production chain. We partner with universities, research organisations, and experts across the globe to give you tools and technology to select the best bulls.
With our solutions, you can continuously improve the genetic gain for each generation of your herd. Our results are rooted in the long-term relationships with our farmers and the close link between research and implementation. Our commitment is to lead the dairy and beef industry in finding solutions to lower methane emissions and breed long-lasting climate-friendly cows.
Biotechnology
For three decades, Ionis has invented medicines that bring better futures to people with serious diseases. Ionis currently has five marketed medicines and a leading pipeline in neurology, cardiology, and other areas of high patient need. As the pioneer in RNA-targeted medicines, Ionis continues to drive innovation in RNA therapies in addition to advancing new approaches in gene editing. A deep understanding of disease biology and industry-leading technology propels our work, coupled with a passion and urgency to deliver life-changing advances for patients.
Biotechnology
Proteon Pharmaceuticals S.A. uses precision biology for microbiome modulation to improve animal and human health, increasing environmental sustainability and eliminating the unnecessary use of antibiotics.
PROTEON's products improve the economic efficiency in livestock farming and aquaculture, increasing environmental sustainability with natural products that also enhance animal welfare.
Biotechnology
Discovery Park is the ideal environment for life science businesses
to succeed. From state-of-the-art labs and offices to comprehensive
support, we work in partnership with you to provide firm foundations for
every stage of your growth.
Within easy reach of London, our location provides access to a wealth of
resources and opportunities with the freedom to expand, making it the
optimal setting for brilliant minds to unlock the potential of scientific
breakthroughs.
Biotechnology
Anaerobe Systems, Inc. is a biotechnology company based out of 15906 Concord Cir, Morgan Hill, California, United States.
Biotechnology
Founded in 1997, Genedata delivers enterprise solutions to enable Biopharma R&D globally to discover, develop, and manufacture innovative biotherapeutics faster and more efficiently.
Genedata combines computational, scientific, and technical expertise with extensive biopharma R&D domain knowledge to deliver user-friendly solutions that are scalable, open, and aligned with industry processes.
Today, most of the leading pharmaceutical, biotechnology, and agrichemical companies, as well as innovative life science research institutions rely on Genedata.
Genedata is proud to be part of Danaher.
Danaher’s science and technology leadership puts Genedata’s solutions at the forefront of the industry, so they can reach more people. Being part of Danaher means we can offer unparalleled breadth and depth of expertise and solutions to our customers.
Together with Danaher’s other businesses across Biotechnology, Diagnostics and Life Sciences, we unlock the transformative potential of cutting-edge science and technology to improve billions of lives every day.
Biotechnology
Northeast Thailand or ISAN levels up its significance with strategic location to 6 countries in the Greater Mekong Sub-region (GMS) namely, Cambodia, China Laos, Myanmar, Vietnam, Thailand. As Thailand’s largest agricultural area based producer, ISAN now refocuses to become the new destination of biotechnology investment and Bio-Circular-Green (BCG) new economy development of GMS and Asia.
Biotechnology
Xap Therapeutics, formerly known as Rockend Ltd, is a start-up biotechnology company which is developing an innovative, synthetic biology driven platform for cell therapeutics. Based in Cambridge, UK, the company was founded by a group of experienced biotech entrepreneurs with significant funding from well-known US/UK blue-chip VCs. Xap Therapeutics applies CRISPR technology to engineer iPSCs. These iPSCs form the basis of a universal cell platform producing a “chassis” cell, which we can further functionalise into cell therapies by expression of genetically engineered constructs. Our cell products will have the ability to process external cues via engineered receptors and to release various types of cargos upon activation. The ultimate aim is to create novel cell therapies with mechanisms of action that are beyond reach of current approaches, thus bringing a step change improvement in the treatment of serious disease, including autoimmunity and cancer.
We are hiring across a range of R&D functions and are looking to build an exceptional team out of industry and academia. This is a unique career opportunity for talented people to join our growing team, and to contribute to the generation of this exciting synthetic cell therapy platform and future clinical products. You will enjoy a varied and rewarding role and a flexible and dynamic working environment which values innovation and teamwork.
Biotechnology
The Pharma Partnering Summit is an exclusive Life Sciences Industry event, with the aim to help companies expand their network and put together licensing deals, research collaborations and financing. Our platform brings together senior executives from different parts of the world specialising in Business Development & Licensing, Alliance Management, Research Collaborations, M&A and Investment. In addition to identifying products and partners as well as investors, the forum also serves to disseminate knowledge through expert speakers, for the best practices in the field of industry partnerships.
Biotechnology
Pathios Therapeutics are world-leading experts with unique expertise in GPCR drug development, focused on GPR65 as a high-value immunology target with robust genetic links to multiple human diseases. Our clinical-stage oncology programme leverages cutting-edge proprietary genetic insights, transcriptomics, and functional immunology of GPR65 as a key immune cell sensor of acidosis in multiple pathological environments, to bring about a revolutionary new approach to treating a broad spectrum of cancers. We are also building an emerging pipeline in neuroinflammatory and neurodegenerative disorders leveraging the broader immunological roles of this receptor in cell types such as microglia.
Based in in Oxford, UK, Pathios combines a team of experienced scientific leaders with strategic external partnerships. We are supported by top tier investors Canaan, Brandon Capital Partners and Bristol Myers Squibb. Pathios is part of the M:M Bio ecosystem, which integrates experienced drug discovery expertise with stage-appropriate, agile, operational infrastructure that results in companies that are efficient, cost effective, focused and great places to work.
Biotechnology
REGENXBIO is a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy. Since its founding in 2009, REGENXBIO has pioneered the development of AAV Therapeutics, an innovative class of gene therapy medicines. REGENXBIO is advancing a pipeline of AAV Therapeutics for retinal and rare diseases, including ABBV-RGX-314 for the treatment of wet AMD and diabetic retinopathy, being developed in collaboration with AbbVie, RGX-202 for the treatment of Duchenne and RGX-121 for the treatment of MPS II. Thousands of patients have been treated with REGENXBIO’s AAV Therapeutic platform, including Novartis’ ZOLGENSMA for children with spinal muscular atrophy. Designed to be one-time treatments, AAV Therapeutics have the potential to change the way healthcare is delivered for millions of people.
Biotechnology
Optimum Diagnostics offers innovative, efficient and reliable radiology and medical laboratory services to our patients using state of the art facilities that will guarantee quality and improvement in health care delivery in Nigeria and Africa in general.
Biotechnology
Clyz lab is an independent biotechnology research laboratory (CRO), specializing in Discovery, Early Phase and Pre-clinical characterization and testing of Biopharmaceutical Products and/or candidate molecules utilising advanced cell culture techniques and assays.
Following Contract Research Services are available:
- In-vitro Drug Toxicity Screening:
Clyz labs is able to pursue in-vitro drug toxicity studies which will enable clients to reduce the costs on the failures in Phase 1 and animal studies.
- PreClinical Drug Screening:
Cancer affects a heterogeneous population, in which one drug will not work for all patients. Though the identification of predictive biomarkers and genetic signatures in the patient population could greatly facilitate stratification in the clinic, partnership with CLYZ Labs will enable clients to test the candidate drugs on heterogeneous 3D human tissue samples increasing the chances of success for new agents. Clyz labs can reproduce various clinical trial designs in a laboratory setting, which will enable clients to make informed decisions on lead candidates and patient selection whilst reducing costs and time to market accelerating drug discovery process to improve global cancer care.
At Clyz Labs we use advanced 3D Culture techniques to personalise cancer medicine. We are interested in applying this knowledge to find new ways to selectively eliminate cancer cells and accelerate drug development of new medicines. We are also actively looking to engage in training the next generation of scientists at the undergraduate, graduate and postdoctoral level. We are working to become an organization that will generate opportunities for wealth creation for the nation and, thereby, enhance the quality of life for its people.
Biotechnology
Palvella Therapeutics (NASDAQ: PVLA) is a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare genetic skin diseases for which there are no FDA-approved therapies. The Company is developing a broad pipeline of product candidates based on its patented QTORIN™ platform, with an initial focus on serious, rare genetic skin diseases, many of which are lifelong in nature. Its lead product candidate, QTORIN 3.9% rapamycin anhydrous gel (QTORIN™ rapamycin), is currently in clinical development for microcystic lymphatic malformations (microcystic LMs) and cutaneous venous malformations. For more information, please go to www.palvellatx.com.
Biotechnology
The Vitrolife Group is a world-leading global provider of medical devices and genetic testing testing solutions. Dedicated to the reproductive-health market since 1994, we have grown by focusing on product development, groundbreaking research, consistent quality control and acquisitions of innovative companies in the industry.
In 2021, Vitrolife acquired Igenomix, a leader in reproductive genetic testing services primarily for IVF clinics. Together we are now the Vitrolife Group, a global leader in reproductive health focused on supporting our customers and patients worldwide to improve treatment outcomes – always with sustainability in mind. Based on science and advanced research capabilities, our aim is to deliver products and services for the entire reproductive-health journey, providing consistent performance and guaranteed quality.
Currently, we are approximately 1,100 people worldwide headquartered in Gothenburg, Sweden. Our products and services are available in more than 125 countries, through our own presence in more than 25 countries and a vast network of distributors for the rest of the world. We are on a mission to be the leading valued solution provider in reproductive health and to support customers with successful treatment outcomes.
Biotechnology
Seed Therapeutics is pioneering the science of improving human health by creating “molecular glues”: novel therapeutics that degrade disease-causing proteins that have heretofore remained “undruggable.”
Through ongoing collaborations with world-leading academic experts in the field, and in partnership with seasoned drug development and commercialization experts, Seed Therapeutics is establishing a growing pipeline of exciting drug candidates on a path to clinical and commercial success.
Our mission is to positively impact human health by creating novel protein degradation therapeutics for the treatment of severe diseases for which health care professionals currently have limited options to offer to patients.
Biotechnology
uFraction8 builds products around a disruptive new liquid particle processing technology. Following our world leading research, establishing new levels of throughput for massively multiplexed microfluidic devices, our technology will be the key to unlock a prosperous and sustainable future.
Our technology offers superior performance and cost savings against the big three liquid processing technologies of filtration, flow centrifugation and flocculation. High volume applications benefit by our unique ability to granularly match targeted volumetric throughputs and our ability to scale this beyond the physical limitations of competing technologies.
Maintaining an unobstructed flow path allows our technology to continue operation in even high suspended solid applications, with operation up to 46% volume fraction maintaining 99.6% +/-0.3% efficiency. Recovery of targeted particles is not hampered by penetration into pores, allowing unmatched recovery from low initial concentration. Particles can be selected out by size with single digit micron precision to ensure only those of interest are extracted, simplifying any subsequent detection or processing.
Our planned products will benefit the world in substantial ways, enhancing food security, increasing access to medicines and nutrients, preserving ocean life and enhancing operational capabilities of humanitarian aid missions.
Beginning our journey, developments are focusing on the most immediately impactful area of sustainable bioproduction. Hampered by the high costs of downstream processing from closed bioreactor systems, our products energy efficiency, non-dependence on consumables or pre-concentration and scalability will unlock economies of scale to achieve dramatic increase in global biomass production. Made with SS316L wettable components, customers using fresh or saltwater producing acids, bases, solvents and aromatics can safely scale their production capabilities and drastically reduce their costs.
Biotechnology
Sable Systems International is the world leader for precision metabolic measurement. We merge authoritative expertise in metabolic physiology and biophysics with an inventive spark to create precision tools for metabolic measurement, neurophysiology and environmental science. The spectrum of applications that can benefit from Sable Systems solutions is vast – from animal biology to pharmaceutical safety testing, human exercise energetics to insect metabolism, and atmospheric monitoring and control. The principles are elegantly simple: measure and control O2, CO2, H2O, methane, pressure and temperature – and do it very well. Our compact, turnkey solutions for high-resolution gas analysis and control, respirometry, indirect calorimetry and animal behavior measurement produce high-definition results.
Biotechnology
Antiverse is a Welsh techbio company specialising in antibody design for challenging drug targets, such as GPCRs and ion channels. We exist to create new enabling technologies that bring new therapies to patients to change lives.
Headquartered in Cardiff, UK and with offices in Boston, MA, we combine state-of-the-art machine learning techniques and advanced cell line engineering to develop de novo antibody therapeutics.
Biotechnology
Aadi Bioscience Inc. (Aadi) is a biopharmaceutical company focused on precision therapies for genetically-defined cancers.
We strive to unleash the potential of mTOR inhibition by employing precision medicine & nanoparticle technology to bring transformational therapies to cancer patients with mTOR pathway driver alterations. Our lead product has been FDA-approved for the treatment of adult patients with locally advanced unresectable or metastatic malignant perivascular epithelioid cell tumors (PEComa).
In March 2025, we became a wholly-owned subsidiary of KAKEN Pharmaceutical Co., Ltd., an R&D driven pharmaceutical company in Japan. A science-first mindset and patient-centric approach is always in our genes. Together with KAKEN, we continue to dedicate to developing products for cancers with mTOR pathway driver alterations.
For more information, please visit: https://aadibio.com/ and https://www.kaken.co.jp/english/.
Biotechnology
RoslinCT is a leading global contract development and manufacturing services organization (CDMO) focused on Advanced Cell and Gene Therapies.
Established in 2006 and built upon the groundbreaking technology cloning of Dolly the Sheep at the Roslin Institute in 1997, RoslinCT has harnessed cutting-edge science to advance the development of human medicines. With a remarkable heritage in the field, the company has achieved significant milestones, including being among the first in the world to produce clinical-grade human pluripotent stem cells and advancing the first CRISPR-edited stem cell-based therapy for a major disease to marketing authorization.
Equipped with 22 purpose-built cGMP cell therapy processing suites in Edinburgh, Scotland, and Hopkinton, Massachusetts, RoslinCT provides innovative process and analytical development, cGMP clinical and commercial manufacturing for a range of cell types for both autologous and allogeneic processes, and cGMP iPSC cell line development, gene editing, and differentiation.
With tailored CDMO solutions, RoslinCT enables partners to efficiently progress from development to commercialization and deliver life-saving Cell and Gene Therapies worldwide. Discover more about our services at www.roslinct.com.
Biotechnology
Cell aging is the underlying driver of modern diseases and therefore cell rejuvenation provides one of the greatest opportunities in drug development. Shift has built proprietary datasets that uncover the hidden biology of cell aging and rejuvenation, revealing single genes that rejuvenate multiple cell types with improved safety, small molecule targets and a connection to fibrosis. This raises the prospect of lifespan-impacting therapeutics developed for age driven indications.
Biotechnology
Canfield Scientific, Inc., is the global leader in imaging systems services and products for healthcare and scientific research applications. Canfield offers leading edge clinical imaging solutions for medical practices and skin care professionals as well as the pharmaceutical, biotechnology and cosmetics industries. Driven by a quality-focused mission to provide best-in-class products and services, Canfield has achieved an industry-wide reputation for excellence and innovation.
Biotechnology
Building cutting-edge biosensor technology. Leveraging the latest advances in biochemistry and nanotechnology to gain access to data we have never been able to access before.
Biotechnology
We have set out to revolutionise the field of personalised cancer diagnostics by providing AI-driven point-of-care solutions to improve clinical outcomes in cancer patients. Our vision extends beyond this, as we aim to unlock point-of-need personalised diagnostics solutions for medical professionals and individuals alike within various medical domains.
Biotechnology
Bactobio is a London-based biotechnology company that uses breakthroughs in genomics, machine learning and bioengineering to culture the 99% of microbes that have previously been unculturable.
Our exclusive access to nature’s greatest bioresource allows us to unlock novel chemistries that have evolved to be effective, specific and biodegradable.
Our first targets are to discover novel antibiotics against the worst bacterial infections and help make plant protection sustainable.
Biotechnology
AMS (Pvt) Ltd. is a Pakistan based company, actively involved in marketing of Analytical / Life Science Instruments of highest repute.
AMS (Pvt.) Ltd. Represents in Pakistan few of the world’s largest developers and manufacturers of Biotechnology, Analytical and Nanotechnology instruments. With over 2,000 major installations in Pakistan. We have a very large customer base among public and private sector organizations in Pakistan. By, far we are the largest company in our field in Pakistan. Our customers include petroleum, mining, pharmaceutical, environment, tanneries, armed forces, research organizations, scientists, hospitals, universities and foreign funded projects. All this is of-course possible through a team of very active and unbeatable sales and service group called as AMS.
AMS have successfully supplied, installed and is now providing back-up services to diverse range of high tech. instruments which includes Electron Microscopes, Gas/Liquid Chromatographs, Atomic Absorption Spectrometers, UV/Vis Spectrophotometers, DNA Synthesizers, Genetic Analysis Systems, Automated Protein Sequencers, and Petroleum Testing Equipments etc.
The company is staffed by some of the best people of their field available in the country. AMS corporate headquarter is in Karachi with major branch offices in Islamabad, Lahore and Peshawar.
Biotechnology
We are a biotechnology start-up, focused on harnessing the potential of fungi to develop innovative, high-value products that enhance the health of our entire ecosystem, paving the way for a sustainable future for our planet.
Biotechnology
Solein is a game-changing protein for the global food industry. Produced from air – CO2, water, nitrogen – and electricity, our unique natural single-cell proteins are not dependent on agriculture, weather or the climate. Creating the future of sustainable food with an unlimited diversity of proteins. #NextGenEU #NextGenerationEU
Biotechnology
With more than twenty years of hands-on experience in pharmaceutical, cosmetic and food biotech industry, our scientists and technical staff developed skills ranging from microbial fermentation process development, to process scale up and recovery of products.
Biosphere provides qualified contract R&D and manufacturing services for the production of microbial biomass, enzymes and metabolites.
Biosphere collaborates with companies, universities, research institutes and scientific networks in several research projects, with private or public funding.
The contract R&D service is mainly addressed to the study of new enzymes for the pharmaceutical sector, the improvement and innovation of traditional products and valorisation of by-products in the food and feed sectors, the study of innovative solutions in the field of green chemistry and renewable energy.
Biotechnology
Huminn Convergence Innovation™ operates on the principle that nature is an interdependent and complex system in order to benefit the entire network and not just its separate domains
Convergence Innovation™ Uniquely integrated Platform:
Huminn is an innovations company at the forefront of science and technology. Working with leading, interdisciplinary scientists, Huminn deploys cutting-edge precision molecular biology tools with proprietary and novel statistical rediction algorithms to create and commercialize visionary integrated solutions to critical global challenges in health, wellness and sustainable development
Huminn connects dots - Others compartmentalize. Huminn connects dots. Others see problems. Huminn marries new tech, new thinking, and a new cast of collaborators to create sustainable solutions that have significant positive economic, environmental and cultural impact
Biotechnology
Oxitec is a team of passionate individuals from 15 countries improving lives and livelihoods by developing the world's first safe, self-limiting technology to control pests that transmit diseases, destroy crops and harm livestock.
Our technology platform allows us to build safe, non-toxic, species-specific, and self-limiting control solutions to a range of damaging insects. We work in close partnerships with governments, foundations, companies and communities around the world and have demonstrated excellence in targeted insect suppression, biosafety, environmental sustainability, regulatory approvals, public acceptance, and scalability.
We are growing, so people who share our desire to have impact globally are encouraged to get in touch.
Biotechnology
Eagle Seeds was founded in 1982 in a small town Alote in Central India. Within a short span, it has emerged as a pioneer in the field of Soybean, Wheat and Vegetable seeds and the "Eagle" brand today is considered as one of the most recognized and respected seed brands in the country. We have successfully traveled through challenging times and reached new horizons. After gaining repute and experience in the field of seed crops, we plan to foray into the field of biotech research. Our mission is to exploit the potential areas in biotechnology for the benefit and prosperity of the Indian farmer.
With a history that spans over a few decades, you can count on Eagle Seeds' experience and stability to help you succeed in today's challenging agricultural environment. Eagle Seeds' state-of-the-art research capabilities have enabled growers to provide quality seeds and many new varieties over the few years. This dedication to be progressive and innovative continues till today.
The company has a sales network, production facilities, field testing sites, and product lines that span over the major states in India. We have got the best of manufacturing, processing and storage facilities that meet the international standards. With skilled staff, the company is capable of rendering top-notch services to all the clients and growers.
The experience of Indian conditions enables us to give you products that are unique to your region's conditions. We are able to assist you throughout the growing season no matter where you farm. Eagle Seeds' heritage, combined with its technology and research, makes it your best bet for quality seed and technical support.
Biotechnology
Plant Health Care is a leading provider of scientifically proven biological products for agriculture. The Company offers products to improve the health, vigor and yield of major field crops such as corn, soybeans, cotton and rice, as well as specialty crops such as fruits and vegetables.
Our innovative line of patent protected products provides both economic and environmental benefits for our customers and capitalizes upon long-term trends towards natural systems and biological solutions to promote plant health and growth.
Plant Health Care has global reach through operating subsidiaries and supply agreements with major industry an distribution partners.
Biotechnology
ARG is an independent agronomy research group, who are passionate about product research and development while taking great care and consideration of the environmental impact.
ARG’s consultancy service to test sports turf, horticulture and agriculture specific solutions and product evaluation for its customers.
ARG has its own in-house facilities, external links to Universities and Organisations and additional facilities in the surrounding areas these include:
• Agronomy Laboratory
• Microbial development and analysis laboratory
• Product Screening Laboratory
• Commercial Greenhouse
• Fine Turf Areas, Greens, Tees, and Fairways
• Access to Agriculture and Horticulture partners
Biotechnology
Cryogenetics offers services and technology for an effective fish reproduction. Our main service has traditionally been the cryopreservation of fish milt. Cryopreservation is a powerful tool for preservation of genetic diversity in wild species and as an integral part of both commercial aquaculture and other fish breeding programs.
In addition to cryopreservation and storage services the company also offers several other products and services helping to secure more effective fish reproduction. These include technology for fresh storage of milt, milt quality evaluation and gender testing of fingerlings.
Biotechnology
ReproTech is committed to maintaining the highest level of expertise in the reproductive tissue banking industry by ensuring the safety and accuracy of the tissues entrusted to us. Our rigorous quality controls ensure that shipments are safe and efficient, and we believe in the highest standards of safe storage for our clients' cryopreserved reproductive tissues which include frequent manual tank inspections and sophisticated 24/7 monitoring systems and analysis. We are dedicated to assisting our clinical partners with regulatory compliance in the areas of tissue storage, donor gametes, and donor embryos.
Biotechnology
Since its inception over a decade ago, CRISPR Therapeutics has evolved from a research-stage company advancing gene editing programs into a leader that celebrated the historic approval of the first-ever CRISPR-based therapy. The Company has a diverse portfolio of product candidates across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine, cardiovascular, autoimmune, and rare diseases. In 2018, CRISPR Therapeutics advanced the first-ever CRISPR/Cas9 gene-edited therapy into the clinic to investigate the treatment of sickle cell disease and transfusion-dependent beta thalassemia. Beginning in late 2023, CASGEVY® (exagamglogene autotemcel [exa-cel]) was approved in several countries to treat eligible patients with either of these conditions. The Nobel Prize-winning CRISPR technology has revolutionized biomedical research and represents a powerful, clinically validated approach with the potential to create a new class of potentially transformative medicines. To accelerate and expand its efforts, CRISPR Therapeutics has formed strategic partnerships with leading companies including Vertex Pharmaceuticals. CRISPR Therapeutics AG is headquartered in Zug, Switzerland, with its wholly-owned U.S. subsidiary, CRISPR Therapeutics, Inc., and R&D operations based in Boston, Massachusetts and San Francisco, California.
Biotechnology
We are a team of dedicated scientists striving to advance treatments in multiple indications in our cell therapy platform. Our mission is to utilize the power of genetics to deliver life-transformative cell therapies by unlocking the potential of engineered cellular medicine.
Biotechnology
Chr. Hansen has combined with Novozymes to become Novonesis: linkedin.com/company/novonesis. This global biosolutions company of 10,000 people is transforming how the world produces, consumes and lives. In 30-plus industries, its biosolutions help businesses meet their needs and the needs of our planet.
Chr. Hansen was founded in 1874 by the Danish pharmacist Christian D. A. Hansen who invented an industrial process to extract rennet for cheese making. The company was a microbial powerhouse that developed natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries. Its unique microbial and fermentation technology platforms and collection of around 50,000 microbial strains helped it meet its commitment to grow a better world. Naturally.
In December 2022, Chr. Hansen and Novozymes entered into an agreement to create a leading global biosolutions partner by combining the two companies. The goal was to unleash the full potential of biosolutions and generate significant value for all stakeholders and society. The combination was completed on January 29, 2024, and Novonesis was born. The name means ‘a new beginning’ and is derived from the Greek word ‘genesis’. It reflects a new era where we’ll better our world with biology. You can find Novonesis on LinkedIn here: linkedin.com/company/novonesis.
Chr. Hansen A/S, part of Novonesis Group.
Biotechnology
Biometrics FSP provider
Biotechnology
BIOMED LAB is the first private laboratory for molecular diagnostics in Macedonia.
The laboratory is equipped with modern equipment which enables fast and accurate results for molecular diagnostic methods. Our commitment is to provide fast, accurate and adjusted genetic testing, improving our capabilities and expertise to keep up with new technologies, and maintaining our dedication to quality.
The team daily works to increase the number of new analyzes in accordance with the most sophisticated methods in the field.
Within the laboratory exists and Research Department for analyzing important biological processes on a molecular level in order to improve human health.
Also, BIOMED LAB performs laboratory and consultative - professional services.
Biotechnology
Genetic testing and counselling, preventive genetic, pharmacogenetic, forensic testing, paternity, relationship testing, allergies and intolerances to food, environmental factors, E-numbers, testing of mineral and vitamin deficiencies...
Biotechnology
Developing a blood-based DNA methylation test for early cancer detection leveraging the latest technology in DNA methylation testing and AI classification
Biotechnology
Iribov is an international plant breeding support laboratory founded in 1992, employing around 600 people in 4 locations: in The Netherlands (Heerhugowaard), Macedonia (Vinica), Ghana (Sogakope) and Brasil.
The services of Iribov can be divided into 4 segments:
𝗣𝗹𝗮𝗻𝘁 𝗧𝗶𝘀𝘀𝘂𝗲 𝗖𝘂𝗹𝘁𝘂𝗿𝗲: Initiation, Virus Elimination, Naktuinbouw Elite certified production, Stock Maintainance, Protocol Development, Large Scale Propagation.
𝗕𝗿𝗲𝗲𝗱𝗶𝗻𝗴 𝗦𝘂𝗽𝗽𝗼𝗿𝘁: Gene Bank Storage in Tissue Culture, Interspecific crossing, Embryo Rescue, Mutation Induction, Dihaploid production, Polyploidization, Marker Assisted Breeding, Crispr-Cas (future development).
𝗔𝗻𝗮𝗹𝘆𝘁𝗶𝗰𝗮𝗹 𝗦𝗲𝗿𝘃𝗶𝗰𝗲𝘀: Plant pathogen detection (PCR), Seed quality control, Flowcytometry, Cytology, Biochemical Assays, Bioassays.
Hardening: automated planting of tissue culture plants, vertical farm facilities, automated grading and sorting, various growing compartments and -specifications, tailor made growing solutions.
The portfolio of Iribov covers over 450 plant species in 10.000 varieties for the ornamental horticulture, vegetable and (soft)fruit companies and the plantation industry worldwide.
Biotechnology
Labena d.o.o. is a company with over 30 years of experience in representing, selling and distributing products in the food, medical, pharmaceutical industries, life science and diagnostic laboratories. We offer products from world-renowned manufacturers with the aim of facilitating research work for scientists and quality reliable and fast results for laboratories and diagnostics. We follow the needs of the market and end users as well as the latest technological achievements in order to remain one of the leading partners in the design, equipment and training for working with high-tech equipment. As a group, we are present in Slovenia, Croatia, Bosnia and Herzegovina, Macedonia, Montenegro and Serbia.
With our labs we provide services, solutions and support to local and global bio pharmaceutical and biotechnology companies, as well as clinical, research and academic institutions in the field of analytics, molecular biology, microbiology and protein biochemistry.
Biotechnology
Building the Collective Digital Immune System for Longevity
We use decentralized artificial intelligence to build a framework for applications to search, discover, and compute on personal omics and biomarker data. By leveraging machine learning, advanced cryptography, and autonomous agents based on a privacy-preserving Identity infrastructure, our blockchain-mediated collective learning system enables individuals and multiple stakeholders in the health sector to build a shared machine learning model without needing to rely on a central authority, and without revealing any datasets to other stakeholders.
The NOMIX team consists of curious experts in the fields of AI/ML, blockchain technology, cryptography, bioinformatics, bioengineering, and company building. Our work is based on the core principles of eco-responsibility, sustainability, transparency, regulatory compliance, scalability, and reliability.
Biotechnology
Discovery Life Sciences, the Biospecimen and Biomarker Specialists™, is a leading provider of highly characterized human biospecimens and cellular starting materials integrated with expert multi-omic analytical services to advance cell and gene therapy and precision medicine programs for cancer, infectious disease, and other complex conditions.
Our robust biospecimen and biomarker platform is optimized for speed and large scale capacity. We routinely manage hundreds of studies and expertly test thousands of biospecimens simultaneously as a single vendor - eliminating time consuming and inefficient transfers of biospecimens or data between different vendors. We offer one of the largest recallable donor pools, Research Use Only (RUO) and clinical-grade (GMP) fresh and cryopreserved human cellular materials to support cell and gene therapy programs at any scale from start to finish. Leading biopharma, diagnostic and academic institutions trust us to quickly deliver high-quality biospecimens and reliable, reproducible biomarker data, so they can outpace their competition and push the leading edge of innovation.
Visit www.dls.com to learn more
Biotechnology
Company Name | Location | Category | Employees | Accuracy | Website | |
|---|---|---|---|---|---|---|
Stevenage , United Kingdom (UK) | Science and Engineering Science and Engineering | 10-20 | info@axitan.com | http://axitan.com/ | ||
Manchester, United Kingdom (UK) | Science and Engineering Science and Engineering | 2-10 | info@linkbiologics.co.uk | http://www.linkbiologics.co.uk | ||
Randers SØ, Denmark | Science and Engineering Science and Engineering | 100-150 | info@vikinggenetics.com | https://www.vikinggenetics.com/ | ||
Carlsbad, United States (US) | Science and Engineering Science and Engineering | 500-1000 | adverseevent@ionis.com | http://www.ionis.com | ||
Lodz, Poland | Science and Engineering Science and Engineering | 50-100 | contact@proteonpharma.com | http://www.proteonpharma.com | ||
Sandwich, United Kingdom (UK) | Science and Engineering Science and Engineering | 50-100 | info@discovery-park.co.uk | http://www.discovery-park.co.uk/ | ||
Morgan Hill, United States (US) | Science and Engineering Science and Engineering | 50-100 | info@anaerobesystems.com | http://www.anaerobesystems.com | ||
Basel, Switzerland | Science and Engineering Science and Engineering | 200-500 | info@genedata.com | http://www.genedata.com | ||
Khon Kaen, Thailand | Science and Engineering Science and Engineering | 2-10 | info@labfutureexpo.com | https://www.labfutureexpo.com/ | ||
Cambridge, United Kingdom (UK) | Science and Engineering Science and Engineering | 20-30 | info@xaptherapeutics.com | http://www.xaptherapeutics.com | ||
London, United Kingdom (UK) | Science and Engineering Science and Engineering | 20-30 | info@pharma-partnering-summit.com | http://www.pharma-partnering-summit.com | ||
Milton, United Kingdom (UK) | Science and Engineering Science and Engineering | 2-10 | info@pathios.com | http://www.pathios.com | ||
Rockville, United States (US) | Science and Engineering Science and Engineering | 200-500 | info@regenxbio.com | https://www.regenxbio.com | ||
Kano, Nigeria | Science and Engineering Science and Engineering | 10-20 | info@optimumng.com.ng | http://optimumng.com | ||
Nether Alderley, United Kingdom (UK) | Science and Engineering Science and Engineering | 2-10 | info@cancertain.com | http://www.clyzlabs.co.uk | ||
Wayne, United States (US) | Science and Engineering Science and Engineering | 20-30 | info@palvellatx.com | https://palvellatx.com/ | ||
Guildford, United Kingdom (UK) | Science and Engineering Science and Engineering | 10-20 | info.uk@igenomix.com | https://www.igenomix.co.uk/ | ||
New York, United States (US) | Science and Engineering Science and Engineering | 20-30 | info@SeedTherapeutics.com | http://www.SeedTherapeutics.com | ||
Falkirk, United Kingdom (UK) | Science and Engineering Science and Engineering | 2-10 | info@ufraction8.com | http://www.ufraction8.com | ||
North Las Vegas, United States (US) | Science and Engineering Science and Engineering | 50-100 | info@sablesys.com | http://www.sablesys.com | ||
Cardiff, United Kingdom (UK) | Science and Engineering Science and Engineering | 20-30 | info@antiverse.io | https://www.antiverse.io/?utm_source=linkedin&utm_medium=social&utm_campaign=linkedin-homepage | ||
Morristown, United States (US) | Science and Engineering Science and Engineering | 20-30 | info@aadibio.com | https://aadibio.com/ | ||
Edinburgh, United Kingdom (UK) | Science and Engineering Science and Engineering | 200-500 | info@roslinct.com | http://www.roslinct.com | ||
Cambridge, United Kingdom (UK) | Science and Engineering Science and Engineering | 20-30 | info@shiftbioscience.com | https://shiftbioscience.com | ||
Parsippany, United States (US) | Science and Engineering Science and Engineering | 200-500 | Info@canfieldsci.com | http://www.canfieldsci.com | ||
San Francisco, United States (US) | Science and Engineering Science and Engineering | 2-10 | contact@levelzerohealth.com | https://www.levelzerohealth.com/ | ||
London, United Kingdom (UK) | Science and Engineering Science and Engineering | 2-10 | info@hq-science.com | http://hq-science.com | ||
London, United Kingdom (UK) | Science and Engineering Science and Engineering | 50-100 | info@bacto.bio | http://bacto.bio | ||
Karachi, Pakistan | Science and Engineering Science and Engineering | 200-500 | amskhi@amspvtltd.com | http://www.amspvtltd.com | ||
Ruan High Lanes, United Kingdom (UK) | Science and Engineering Science and Engineering | 10-20 | info@controlledextracts.com | http://www.controlledextracts.com | ||
Helsinki, Finland | Science and Engineering Science and Engineering | 20-30 | info@solarfoods.com | http://www.solarfoods.com/ | ||
Forlì (Forlì-Cesena), Italy | Science and Engineering Science and Engineering | 20-30 | info@biospheresrl.com | http://www.biospheresrl.com | ||
New York, United States (US) | Science and Engineering Science and Engineering | 10-20 | info@nr-s.net | https://nr-s.net | ||
Oxford, United Kingdom (UK) | Science and Engineering Science and Engineering | 100-150 | info@oxitec.com | http://www.oxitec.com | ||
Indore, India | Science and Engineering Science and Engineering | 200-500 | info@eagleseeds.com | http://www.eagleseeds.com | ||
Holly Springs, United States (US) | Science and Engineering Science and Engineering | 50-100 | info@planthealthcare.com | http://www.planthealthcare.com | ||
Bingley, United Kingdom (UK) | Science and Engineering Science and Engineering | 2-10 | timb@hitas.co.uk | https://agronomyresearchgroup.co.uk/ | ||
Hamar, Norway | Science and Engineering Science and Engineering | 10-20 | sales@cryogenetics.com | http://www.cryogenetics.com | ||
Coconut Creek, United States (US) | Science and Engineering Science and Engineering | 100-150 | info@reprotech.com | https://www.reprotech.com | ||
Boston, United States (US) | Science and Engineering Science and Engineering | 200-500 | info@crisprtx.com | http://www.crisprtx.com | ||
Baltimore, United States (US) | Science and Engineering Science and Engineering | 2-10 | info@vitatx.com | https://www.vitatx.com/ | ||
Hørsholm, Denmark | Science and Engineering Science and Engineering | 5000+ | hello@novonesis.com | http://www.novonesis.com | ||
Pittsburgh, United States (US) | Science and Engineering Science and Engineering | 10-20 | info@clinstone.com | http://www.clinstone.com | ||
Ohrid, Macedonia | Science and Engineering Science and Engineering | 2-10 | contact@biomedlab.mk | http://www.biomedlab.mk | ||
Karposh, Macedonia | Science and Engineering Science and Engineering | 2-10 | contact@g-life.care | http://www.g-life.care | ||
Skopje, Macedonia | Science and Engineering Science and Engineering | 2-10 | info@fingerprintdx.com | https://www.fingerprintdx.com/ | ||
Heerhugowaard, The Netherlands | Science and Engineering Science and Engineering | 500-1000 | info@iribov.com | http://www.iribov.com | ||
Skopje, Macedonia | Science and Engineering Science and Engineering | 2-10 | info@labena.mk | https://labena.mk/ | ||
Munich, Germany | Science and Engineering Science and Engineering | 50-100 | info@nomix.ai | https://nomix.ai | ||
Huntsville, United States (US) | Science and Engineering Science and Engineering | 500-1000 | info@dls.com | http://www.dls.com |
50/792 results
Frequently asked questions
FAQ updated November 2025
What is Enterprise League?
Enterprise League is a business platform built for the doers, small businesses and startups who want to get seen, get leads, and grow.We help you showcase your company, connect directly with potential clients and partners, and get valuable insights into your performance, all without the middlemen or the fluff. Whether you're a team of 2 or 200, Enterprise League puts you on equal ground with the big players.
How can my business benefit from joining Enterprise League?
You get visibility, leads, and control, all in one place. Joining Enterprise League puts your business in front of thousands of verified companies. List your services, connect with decision-makers, and see real-time data on who’s visiting your profile.It’s a streamlined way to grow your presence, build partnerships, and stop relying on outdated directories or cold outreach.
What are the key features of Enterprise League?
Enterprise League gives you tools to grow faster: • Custom Profiles:Boos your visibility with a standout business profile. • Smart search: Get found by clients looking for your exact services. • Real analytics: See who's visiting, what's working and where you rank. • Direct messaging: Skip the cold emails and chat direct with prospects. • Reviews insights: Showcase real reviews and let AI highlight what matters. • Zero-fee marketplace: List and find products or services for free.
How does the company verification process work?
Get verified for the price of a coffee $0 Verified companies appear higher in search, build trust faster, and unlock an extra features. One badge. More business.
Can I try Enterprise League for free?
Absolutely. Our Free Plan is built for small businesses. You get profile visibility, marketplace access, and business directory use, free. Want more reach and features? Upgrade when you’re ready. No pressure.
How does the Interactive Business Directory work?
It’s like Google, but only for serious businesses. Search by location, size, or sector. Visit company profiles, send a message, or download insights. It’s built for real B2B decisions, not noise.
How can I download business insights?
Need competitor or market data? We’ve got it, and yes, you can download it. With our Business Insights Download feature, you can export detailed company and industry data in CSV format, including decision-makers, background info, and more. It’s perfect for sales targeting, market research, or just getting smarter about your next move.
How does the Reviews feature work?
Show off your best reviews, without lifting a finger. We pull your reviews from Google, Facebook, Trustpilot and more. Then our AI highlights the most important insights. You just sit back and shine.
What plans are available?
Three simple plans: Free Plan: Get started with a verified profile, search access, and the ability to add products and services. Premium: More reach, more leads, deeper analytics. Ultimate: All the bells and whistles, including a dedicated growth partner.
How can my company win an award?
We highlight the best of the best, and that could be you. We run 50+ startup award categories every year. Apply for free. Winners get recognition, visibility, and bragging rights.